Return to Listing

1 result(s) for

PI Name Protocol # Title
Alexey Danilov STUDY00018655 A Phase I Study of PI3Kα,δ Inhibitor Copanlisib in Combination with PD-1 Antagonist Nivolumab in Patients with Transformed Chronic Lymphocytic Leukemia (Richter’s Transformation) or Non-Hodgkin Lymphoma

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080